GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001065.PFD) » Definitions » Repurchase of Stock

JW Pharmaceutical (XKRX:001065.PFD) Repurchase of Stock : ₩-332.45 Mil (TTM As of Dec. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Repurchase of Stock?

JW Pharmaceutical's Repurchase of Stock for the three months ended in Dec. 2024 was ₩0.00 Mil.

JW Pharmaceutical's Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-332.45 Mil.


JW Pharmaceutical Repurchase of Stock Historical Data

The historical data trend for JW Pharmaceutical's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Repurchase of Stock Chart

JW Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Repurchase of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only -224.25 -412.29 -281.60 -260.88 -750.42

JW Pharmaceutical Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -332.45 - - -

JW Pharmaceutical Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-332.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JW Pharmaceutical Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Pharmaceutical Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines